INDIA—Agilus Diagnostics, an India-based diagnostic laboratory network, has partnered with SEAS International LLC of Oman to open a cutting-edge referral laboratory in Oman.

The company stated that this strategic alliance seeks to provide high-quality diagnostic testing services to Oman’s 5 million people.

The collaboration aims to strengthen the diagnostic service provider’s international offering. Its international network includes various centres and pick-up points (PUPs) throughout the South Asian Association for Regional Cooperation (SAARC), Sub-Saharan Africa, the Commonwealth of Independent States, and the Middle East.

The agreement signing ceremony was attended by key dignitaries such as Dr Ibrahim Aghaithi, Chairman of SEAS International LLC, Ashish Bhatia, Chief Operating Officer of Agilus Diagnostics, and Mangesh Shirodkar, Chief Financial Officer of Agilus Diagnostics, and was presided over by Issa Saleh Abdullah Alshibani, Ambassador of Oman in India.

Speaking during the ceremony, Anand. K, Managing Director & CEO of Agilus Diagnostics, emphasized Oman’s developing healthcare infrastructure and rising privatisation of the sector, which are expected to drive demand for diagnostic testing services in the country.

He went on to say that the relationship with SEAS International strengthens Agilus’ international presence in the Middle East, Sub-Saharan Africa, the Commonwealth of Independent States, and the SAARC area.

He added that their cutting-edge genomics testing solutions, coupled with robust logistics and information management systems, and backed by their 28-year track record of delivering top-notch diagnostic reports, he believes they are well positioned to provide international diagnostic services in Oman.

Dr. Ibrahim Aghaithi, Chairman of SEAS International, On his part, he emphasized the expected expansion of Oman’s in-vitro diagnostics business.

He noted that as the frequency of acute and chronic infectious diseases rises and Oman’s senior population grows, the demand for diagnostics and preventative health checks is projected to skyrocket.

He went on to predict revenue of $99.07 million by 2024, with a compound annual growth rate (CAGR) of 2.32% from 2024 to 2028, resulting in a market volume of $108.60 million by 2028.

Agilus Diagnostics has the largest network of NABL-accredited labs as of March 31, 2023, according to the CRISIL Report, with an extensive diagnostics network in India spread across 25 states and five union territories, covering over 1,000 towns and cities and over 532 districts.

There is also a network of 413 laboratories, 43 of which have been accredited by the National Accreditation Board for Testing and Calibration Laboratories (“NABL”), as well as one Global Reference Lab (GRL) in Mumbai and five regional reference laboratories strategically located in Gurugram in Haryana, Bengaluru in Karnataka, Chennai in Tamil Nadu, Kolkata in West Bengal, and Cochin in Kerala.

So far, Agilus has one College of American Pathologists (CAP)-approved lab in Dubai, two laboratories in Nepal, and more than 800 PUPs, and 17 collecting centres outside India. 

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.